We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-3.69%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.23B
AUM Growth
+$247M
Cap. Flow
+$266M
Cap. Flow %
21.66%
Top 10 Hldgs %
61.87%
Holding
776
New
234
Increased
119
Reduced
104
Closed
282

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$172M
2
FCX icon
Freeport-McMoran
FCX
+$166M
3
TSLA icon
Tesla
TSLA
+$92.7M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$27.5M
5
PFE icon
Pfizer
PFE
+$25.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.5%
2 Healthcare 17.22%
3 Materials 15.97%
4 Technology 5.36%
5 Financials 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALB icon
501
CALL
Albemarle
ALB
$15.5B
-1,500
Closed -$351K
ALL icon
502
Allstate
ALL
$68.2B
-10,840
Closed -$1.27M
AMD icon
503
Advanced Micro Devices
AMD
$767B
-5,733
Closed -$684K
AMED
504
DELISTED
Amedisys
AMED
-4,557
Closed -$738K
AMRC icon
505
Ameresco
AMRC
$1.34B
-5,743
Closed -$468K
AMT icon
506
American Tower
AMT
$78.8B
-5,271
Closed -$1.54M
ANF icon
507
Abercrombie & Fitch
ANF
$5.27B
-8,829
Closed -$308K
ANIP icon
508
ANI Pharmaceuticals
ANIP
$1.74B
-5,471
Closed -$252K
APD icon
509
Air Products & Chemicals
APD
$68.6B
-3,014
Closed -$917K
APO icon
510
Apollo Global Management
APO
$76B
-4,128
Closed -$299K
AQST icon
511
Aquestive Therapeutics
AQST
$538M
-42,028
Closed -$163K
ARAY icon
512
Accuray
ARAY
$34.9M
-16,363
Closed -$78K
ARCC icon
513
Ares Capital
ARCC
$14.3B
-15,397
Closed -$326K
ARKK icon
514
ARK Innovation ETF
ARKK
$6.37B
-20,000
Closed -$1.89M
ARKK icon
515
PUT
ARK Innovation ETF
ARKK
$6.37B
-25,100
Closed -$2.37M
ARLO icon
516
Arlo Technologies
ARLO
$1.59B
-31,195
Closed -$327K
ATLC icon
517
Atlanticus Holdings
ATLC
$1.45B
-8,118
Closed -$579K
OPTU
518
Optimum Communications Inc
OPTU
$306M
-67,215
Closed -$1.09M
AVB icon
519
AvalonBay Communities
AVB
$26.3B
-1,138
Closed -$287K
AXP icon
520
American Express
AXP
$229B
-2,602
Closed -$426K
BABA icon
521
CALL
Alibaba
BABA
$317B
-4,100
Closed -$487K
BBY icon
522
Best Buy
BBY
$17.4B
-3,101
Closed -$315K
BF.B icon
523
Brown-Forman Class B
BF.B
$12.9B
-21,660
Closed -$1.58M
BIIB icon
524
Biogen
BIIB
$30.6B
-2,332
Closed -$559K
BILI icon
525
Bilibili
BILI
$7.95B
-10,980
Closed -$509K

Similar funds

Caxton Associates (New York)'s Q1 2022 Portfolio in Review

As of Q1 2022, Caxton Associates (New York) held 776 positions worth $1.23B, up 25% from $982M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Caxton Associates (New York) deployed $266M of net new capital in Q1 2022, opening 234 new positions and adding to 119 existing holdings. Its largest new stake was Aptiv: 1,293,400 shares worth $155M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 4.8% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Amazon, an estimated $7.44M trimmed.

  • Caxton Associates (New York)'s largest Q1 2022 buy was Aptiv: 1,293,400 shares worth $155M.
  • Caxton Associates (New York) added most to Tesla in Q1 2022, an estimated $92.7M increase.
  • Caxton Associates (New York)'s biggest Q1 2022 reduction was Amazon, cutting an estimated $7.44M.
  • Caxton Associates (New York) fully exited State Street SPDR S&P 500 ETF Trust in Q1 2022, selling an estimated $79M.
  • Caxton Associates (New York)'s ten largest holdings make up 62% of its $1.23B portfolio in Q1 2022.
  • Caxton Associates (New York) opened 234 new positions and closed 282 in Q1 2022.
  • Caxton Associates (New York)'s portfolio value rose 25% quarter-over-quarter to $1.23B.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.